{
    "Trade/Device Name(s)": [
        "Piccolo\u00ae Potassium Test System"
    ],
    "Submitter Information": "Abaxis Inc.",
    "510(k) Number": "K200865",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992140",
        "K051087"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MZV"
    ],
    "Summary Letter Date": "April 2, 2021",
    "Summary Letter Received Date": "April 6, 2021",
    "Submission Date": "October 15, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1600"
    ],
    "Regulation Name(s)": [
        "Potassium Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Potassium"
    ],
    "Specimen Type(s)": [
        "Heparinized whole blood",
        "Heparinized plasma",
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Piccolo\u00ae blood chemistry analyzer",
        "Piccolo Xpress\u00ae chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic colorimetric assay"
    ],
    "Methodologies": [
        "Enzymatic colorimetric assay"
    ],
    "Submission Type(s)": [
        "Test",
        "System",
        "Reagent",
        "Analyzer",
        "Cartridge",
        "Disc"
    ],
    "Document Summary": "FDA 510(k) summary for Piccolo\u00ae Potassium Test System for quantitative determination of potassium using an enzymatic colorimetric assay on the Piccolo Xpress\u00ae chemistry analyzer.",
    "Indications for Use Summary": "In vitro quantitative determination of potassium in heparinized whole blood, heparinized plasma, or serum in clinical laboratory or point-of-care settings to aid diagnosis and treatment of various medical conditions.",
    "fda_folder": "Clinical Chemistry"
}